Search

everythinglearnresearchcommunity

for

Search:↓

A simple screening method found that 6.3% of women in a semiurban area in Sri Lanka have polycystic ovary syndrome, with most showing menstrual irregularities.

Combining liraglutide and metformin helps obese women with PCOS who didn't lose weight on metformin alone to lose more weight.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

Obesity increases the risk of developing polycystic ovary syndrome, and weight loss can improve the condition.

Women with PCOS have different levels of certain fats and proteins in their blood, which could help diagnose the condition.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

Dietary changes, including weight loss and a balanced diet, are important for managing PCOS, especially in overweight women.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

Melatonin may help treat PCOS symptoms in rats.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

Obesity worsens Polycystic Ovary Syndrome symptoms, and weight loss is a key treatment.

The combination therapy improved PCOS symptoms in both obese and non-obese women, with weight loss in the obese group.

The PCOS-specific questionnaire needs more work to fully measure quality of life in clinical trials.

More adolescent girls in urban areas of India have Polycystic Ovary Syndrome compared to those in rural areas.

Chromium supplements don't improve insulin, hormone levels, or cholesterol in women with PCOS but raise testosterone levels.

Higher hs-CRP levels in Indian adolescent women with PCOS are more related to BMI than PCOS itself.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

High levels of male hormones are very common in women with PCOS and affect their metabolism differently depending on their weight.

Women with PCOS often have more sleep problems than the general population.

The document concludes that careful evaluation is needed to diagnose PCOS correctly due to similar symptoms in other conditions, and accurate testosterone level measurement is crucial.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

The study suggests certain ACE gene variations are more common in women with PCOS and may be linked to increased insulin resistance.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

Blood tests are needed to confirm high male hormone levels in women with PCOS, as physical signs alone are not reliable.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.